Question

I am a breastfeeding mother and i want to know if it is safe to use Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer? Is Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer safe for nursing mother and child? Does Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer extracts into breast milk? Does Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer has any long term or short term side effects on infants? Can Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer influence milk supply or can Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer decrease milk supply in lactating mothers?

Answer by DrLact: About Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer usage in lactation

No information is available on the clinical use of Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer during breastfeeding. Because Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer is a large protein molecule with a molecular weight of 145,000, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Until more data become available, Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer should be used with caution or avoided during breastfeeding, especially while nursing a newborn or preterm infant. The manufacturer recommends that breastfeeding be discontinued during Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer therapy and for at least 5 months after the last dose. Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer is a human immunoglobulin G1 (IgG1) antibody. Holder pasteurization (62.5 degrees C for 30 minutes) decreases the concentration of endogenous immunoglobulin G in mature milk by 60 to 79%.[1][2] A study of 67 colostrum samples that underwent Holder pasteurization found that IgG amounts decreased by 34 to 40%. Specific IgG subclasses decreased by different amounts, with IgG1 activity decreasing by about 37%.[3] None of the studies measured IgG activity.

Alternate Drugs

Omalizumab(Low Risk)
Ipilimumab(Unsafe)
Rituximab(Low Risk)
Secukinumab(Low Risk)
Abciximab(Low Risk)
Nivolumab(Unsafe)
Basiliximab(Low Risk)
Bevacizumab(Low Risk)
Belimumab(Low Risk)
Natalizumab(Low Risk)
Ustekinumab(Low Risk)
Trastuzumab(Unsafe)
Cetuximab(Unsafe)
Denosumab(Low Risk)
Cisplatin(Unsafe)
Dacarbazine(Dangerous)
Busulfan(Dangerous)
Fluorouracil(Dangerous)
Alemtuzumab(Low Risk)
Ipilimumab(Unsafe)
Gemcitabine(Dangerous)
Thioguanine(Dangerous)
Rituximab(Low Risk)
Dasatinib(Unsafe)
Docetaxel(Dangerous)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Mitoxantrone(Dangerous)
Dactinomycin(Dangerous)
Trastuzumab(Unsafe)
Nivolumab(Unsafe)
Pazopanib(Unsafe)
Letrozole(Dangerous)
Cetuximab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Exemestane(Dangerous)
Etoposide(Dangerous)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Bleomycin(Dangerous)
Erlotinib(Unsafe)
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Cladribine(Dangerous)
Imatinib(Unsafe)
Vinorelbine(Dangerous)
Ipilimumab(Unsafe)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Glatiramer(Low Risk)
Nivolumab(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.